Quality of life in childhood immune thrombocytopenia: Revision of the Kids' ITP Tools (KIT).
immune thrombocytopenia
paediatric bleeding disorders
quality of life
Journal
British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544
Informations de publication
Date de publication:
27 Jul 2024
27 Jul 2024
Historique:
received:
21
03
2024
accepted:
11
07
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
aheadofprint
Résumé
The Kids ITP Tools (KIT) is a health-related quality of life (HRQoL) questionnaire that evaluates quality of life in children with immune thrombocytopenia (ITP). There are three formats: Child Self-Report, Parent Proxy-Report and Parent Impact-Report. This study aimed to develop a domain structure by grouping-related questions from the questionnaire into domains that independently reflect various aspects of HRQoL. The study was conducted in two phases. Phase 1 involved an online survey distributed to experts to identify conceptual domains for the KIT. Phase 2 utilized a statistical approach to analyse responses from patients with ITP and their families. A revised KIT 2.0 was ultimately developed to aid in treatment decision-making and monitoring of ITP.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 British Society for Haematology and John Wiley & Sons Ltd.
Références
Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. Am J Hematol. 2010;85(3):174–180. https://doi.org/10.1002/ajh.21616
Arnold DM. Immune thrombocytopenia: getting back to basics. Am J Hematol. 2012;87(9):841–842. https://doi.org/10.1002/ajh.23287
Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829–3866. https://doi.org/10.1182/bloodadvances.2019000966
Livingston J, Alrajhi Z, Jackson M, McGuire C, Newhook D, Klaassen RJ, et al. Evaluating the impact of thrombopoietin receptor agonist medications on patient outcomes and quality of life in paediatric immune thrombocytopenia through semi‐structured interviews. Br J Haematol. 2023;200(4):506–516. https://doi.org/10.1111/bjh.18545
Klaassen RJ, Blanchette VS, Barnard D, Wakefield CD, Curtis C, Bradley CS, et al. Validity, reliability, and responsiveness of a new measure of health‐related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP tools. J Pediatr. 2007;150(5):510–515, e1. https://doi.org/10.1016/j.jpeds.2007.01.037
Klaassen RJ, Blanchette V, Burke TA, Wakefield C, Grainger JD, Gaedicke G, et al. Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools. Pediatr Blood Cancer. 2013;60(1):95–100. https://doi.org/10.1002/pbc.24257
Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, et al. Second‐line treatments in children with immune thrombocytopenia: effect on platelet count and patient‐centered outcomes. Am J Hematol. 2019;94(7):741–750. https://doi.org/10.1002/ajh.25479
Zilber R, Bortz AP, Yacobovich J, Yaniv I, Tamary H. Analysis of health‐related quality of life in children with immune thrombocytopenia and their parents using the Kids' ITP tools. J Pediatr Hematol Oncol. 2012;34(1):2. https://doi.org/10.1097/MPH.0b013e3182329b4f
Grainger JD, Young NL, Blanchette VS, Klaassen RJ. Quality of life in immune thrombocytopenia following treatment. Arch Dis Child. 2013;98(11):895–897. https://doi.org/10.1136/archdischild‐2013‐303784
McGuire C, Young NL, Livingston J, Dhir V, Blanchette VS, Kirby‐Allen M, et al. Face validity of the Kid's ITP tools (KIT) in the era of thrombopoietin receptor agonists (TPO‐RAs). Pediatr Blood Cancer. 2024;71:e30888. https://doi.org/10.1002/pbc.30888
Klaassen RJ, Barrowman N, Merelles‐Pulcini M, Vichinsky EP, Sweeters N, Kirby‐Allen M, et al. Validation and reliability of a disease‐specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014;164(3):431–437. https://doi.org/10.1111/bjh.12631
Varni JW, Limbers CA, Burwinkle TM. How young can children reliably and validly self‐report their health‐related quality of life?: an analysis of 8,591 children across age subgroups with the PedsQL™ 4.0 generic core scales. Health Qual Life Outcomes. 2007;5(1):1. https://doi.org/10.1186/1477‐7525‐5‐1
Chaudhury B, Grainger J. UK second‐line paediatric primary ITP therapy analysis. Arch Dis Child. 2021;106(9):929–931. https://doi.org/10.1136/archdischild‐2020‐320646
R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2022 https://www.R‐project.org/
Kaiser HF. An index of factorial simplicity. Psychometrika. 1974;39(1):31–36. https://doi.org/10.1007/BF02291575
Satorra A, Bentler P. Scaling corrections for statistics in covariance structure analysis. Published online May 27 1988 [Cited 2023 Sep 16]. Available from: https://escholarship.org/uc/item/3141h70c
Satorra A, Bentler PM. Corrections to test statistics and standard errors in covariance structure analysis. Latent variables analysis: applications for developmental research. Thousand Oaks: Sage Publications, Inc; 1994. p. 399–419.
Chou CP, Bentler PM, Satorra A. Scaled test statistics and robust standard errors for non‐normal data in covariance structure analysis: a Monte Carlo study. Br J Math Stat Psychol. 1991;44(2):347–357. https://doi.org/10.1111/j.2044‐8317.1991.tb00966.x
Curran PJ, West SG, Finch JF. The robustness of test statistics to nonnormality and specification error in confirmatory factor analysis. Psychol Methods. 1996;1(1):16–29. https://doi.org/10.1037/1082‐989X.1.1.16
Giordano P, Lassandro G, Giona F, Jankovic M, Nardi M, Nobili B, et al. ITP‐QoL questionnaire for children with immune thrombocytopenia: Italian version validation's. J Pediatr Hematol Oncol. 2014;31(6):534–547.
Mokhtar GM, Farid SM, Shaker NM, Farrag KE. Health‐related quality of life of Egyptian children with immune thrombocytopenia and their parents. J Pediatr Hematol Oncol. 2014;36(3):194–199. https://doi.org/10.1097/MPH.0000000000000023